濮阳东方医院治阳痿价格低(濮阳东方看男科病口碑非常高) (今日更新中)

Jill and I send our thoughts to President Trump and First Lady Melania Trump for a swift recovery. We will continue to pray for the health and safety of the president and his family.— Joe Biden (@JoeBiden) October 2, 2020 229

Just over 1 million people filed new jobless claims last week, according to the U.S. Department of Labor’s latest report released Thursday. Another 14.5 million people filed continuing claims, leaving unemployment in the U.S. still startlingly high.Amid high unemployment across the country, a new report is showing executive compensation is growing as CEOs continue to cut millions of jobs.“We find that a CEO now earns about 320 times that of a typical worker in their main industry,” said Lawrence Mishel, a labor economist and distinguished fellow at the Economic Policy Institute, an independent think tank in Washington D.C.Mishel just authored a report analyzing CEO compensation. That report shows how in March and April when some CEOs were reported to have cut their salaries during the economic downturn, it wasn’t as big of a sacrifice as it seemed.“Salaries make up about 5 percent of CEO compensation packages,” explained Mishel. “And it seems like when CEOs say they are making a sacrifice, it’s really, I think, is better for press releases than in that they are actually going to take a cut in their standard of living.”The report shows how CEO compensation growth is affecting workers everywhere.“If you look at CEO compensation since, back over the last four decades since 1978, CEO compensation grew 1,167 percent,” said Mishel. “The compensation of a typical worker grew 13 to 14 percent over that period.”The report shows CEO compensation increased by 14 percent just last year and is set to continue to go up this year, even in a recession with companies having to let go of millions of workers.“The wages of the vast majority, the bottom 90 percent, has grown only half as fast as it otherwise would have had the top 1 percent not really expanded like it did,” Mishel explained.Essentially the “profit pie” has not grown proportionate to CEO compensation growth. So, as CEOs are getting significantly higher compensation, it is taking from the pay other workers.“I think this is a problem of corporate governance and our tax policies, and it needs to be addressed,” said Mishel.Proposed solutions include capping CEO compensation and taxing anything above the cap. EPI also suggests allowing shareholders and company workers to directly have a say in their CEOs' pay. However, both solutions are as controversial as the problem. 2359

JACKSONVILLE, Fla. – A boater who had been missing since Friday was rescued about 86 miles off the coast of Florida on Sunday.The U.S. Coast Guard says 62-year-old Stuart Bee was found alive on the bow of his 32-foot Sea Ray, which had capsized.Bee departed Cape Marina in Port Canaveral on Friday and didn’t return, according to the Coast Guard.Watchstanders in Jacksonville learned of the disappearance Saturday morning and were told Bee wouldn’t typically stay out on his boat overnight.An aircrew was dispatched the area and other boaters were advised to be on the lookout for Bee’s vessel.Luckily, the Coast Guard says Bee was spotted clinging to his boat at about 11 a.m. Sunday and was then transported to shore."Saving lives at sea is our highest calling. This is a truly incredible outcome that demonstrates the bond among all mariners and our community," said Capt. Mark Vlaun, commanding officer of Sector Jacksonville. "Thank you to our mission partners that launch into action and to all who got the word out to find and rescue Mr. Bee"#BREAKING: "Saving lives at sea is our highest calling. This is a truly incredible outcome that demonstrates the bond among all mariners and our community." Full story: https://t.co/LOor1fi0kE pic.twitter.com/hVD1QqvImW— USCGSoutheast (@USCGSoutheast) November 29, 2020 1327

KANSAS CITY, Mo. — Doctors and nurses are celebrating the recovery of a 23-year-old man who spent months in the hospital with a severe COVID-19 infection.In early April, Shakell Avery began feeling some of the COVID-19 symptoms. He went to the emergency room, and within 48 hours, he was on a ventilator fighting for his life due to the virus.After spending months in the hospital, he recovered, thanks to a convalescent plasma donor from New York and medical staff from Menorah Medical Center and Research Medical Center.It's been a celebration ever since his family heard the news their loved one was coming home."You definitely feel the love," Avery said. "It's like they were waiting for a celebrity to come to town."In late June, Shakell's doctors and nurses also celebrated his recovery."As hard as these days have been for some of us on the front line, it's worth it," said Dr. Marjorie Wongs with Menorah Medical Center said. "It makes it worth it."It's a different story from just a few months ago when Avery first contracted the virus.He shared how he felt right before he went to the hospital."I played sports, I played football, and I've never felt body aches like that," Avery said.Ultimately, it was the shortness of breath that worried him and his family."I mean just taking real deep breaths, and I still couldn't get it, and I thought, 'something's wrong,'" Avery said.He spent more than two months at Menorah Medical Center."He had life-threatening COVID-19," Wongs said. "He had severe pneumonia and required a ventilator. He had respiratory failure.""I remember before I went in and then when I woke up at the hospital," Avery said. "I don't really remember much at Menorah."Nurses and staff put up a tent for the family to say hello through the window and draw pictures because they couldn't physically be inside with him at the time.Avery's family said it was such a blessing to see the healthcare staff doing what they could to see their loved one, especially since Avery was in the hospital for a total of 79 days."Initially, you hear two weeks, three weeks," Shakell's mother, Wiletta Avery said. "When he was put on a ventilator, that was the hardest thing for me."Wiletta Avery then heard what no mother wants to hear."On April 11th, 4:30 in the morning, I'll never forget. They call and they're explaining to us that there's nothing they can do for him. He was maxed out on ventilation," Avery's mother said. "At that point they allowed me to go up and see him. And you know, they're not letting people into these hospitals, so when they say, 'You can come up,' you pretty much know what that means as if this will be my last time seeing him."While seeing him, she asked him to do just one thing."I just asked him, I need you to fight for me," she said. "I need you to fight."Wongs said there was a push to get convalescent plasma for Avery, but it wasn't an easy process."We contacted local blood banks; no one had any plasma available. We started looking for donors ourselves," Wongs said. "We even were contemplating flying a donor to another state, to where they could do the collection because we didn't even have collection capabilities in Kansas City until much later."Avery's family members also went to social media, pleading someone who recovered from COVID-19 to help save Shakell's life.They eventually found a donor."We ended up getting a donor from New York City. They were able to ship that plasma to us from the community blood center," Wongs said.They transfused those antibodies into Avery's body."It's experimental. This is the first patient that I had given convalescent plasma to. It's been reported out for other infections, but you know, this was our first patient," Wongs said.And it worked."To see he improved with it was just amazing for us," Wongs said. "I think it is definitely going to be one of the bridging therapies until we get to a vaccine or some sort of a cure. It is definitely one of the first things I go to now in patients that have severe, life-threatening COVID. I know we are using it much more than we were now."Menorah Medical Center and Research Medical Center worked together to make the transfusion happen."We are part of a national clinical trial," Wongs said. "I think we'll have some data that comes out later this summer as to the efficacy of convalescent plasma, but those of us on the ground that are using it, we think the data is going to be promising."Avery was only in his early 20s when he contracted the virus."It's definitely something I don't want anybody to go through," he said. "I just felt real depressed, robbed... like somebody just snatched you out your livelihood."While Avery recovered from the virus, it hasn't been a full overnight recovery."You don't just come home and everything is right back to normal. I had to learn how to walk again, I had to learn how to stand up straight on my own, with no support. I'm still having to learn how to properly get up steps," Avery said. "I used to be active, moving, and now it's just like, everything that you learn that's new, that's second nature to you, you have to relearn. So it's difficult. The fight really ain't over until it's 100 percent over."Avery has a message for young adults his age."When you decide to step outside, no mask, no sanitizer, no care in the world, think about whose father you're taking away from that kid. Think about whose mother you're taking away, whose grandparent, whose daughter, whose son," he said.He said he hopes more people take this virus seriously."Don't think you're invincible, I used to think that," Avery said. "Take this as serious as you would anything else. Take this as serious as life, cause it's that serious."Avery says financially, it's been hard too, as bills didn't stop while he was in the hospital for months and now continues to work on physical therapy.His family has set up a GoFundMe page to help with financial assistance.This story was originally published by Rae Daniel on KSHB in Kansas City. 6012

Johnson & Johnson announced it has paused its coronavirus vaccine trials on Monday following an “unexplained illness” among one of its participants.Johnson & Johnson stressed that adverse events during trials are expected, and a pause gives researchers an opportunity to review all of the medical information before moving forward with the trial. Johnson & Johnson added that it’s not always immediately known if the affected person received a placebo or a study treatment.Among the trials paused was Johnson & Johnson’s multi-country “ENSEMBLE” vaccine, which entered Phase 3 testing in September. Johnson & Johnson said last month that its goal was to seek an emergency use authorization approval in early 2021.The FDA noted that a vaccine candidate must be at least 50% effective to receive emergency use authorization. Vaccine candidates should include a median follow-up duration of at least two months after completion of the full vaccination regimen to help provide adequate information to assess a vaccine’s risk-benefit.According to the FDA, a typical Phase 3 trial would take one to three years.“NIH is committed to supporting several Phase 3 vaccine trials to increase the odds that one or more will be effective in preventing COVID-19 and put us on the road to recovery from this devastating pandemic,” said NIH Director Francis S. Collins, M.D., Ph.D. “We also know that preventing this disease could require multiple vaccines and we’re investing in those that we believe have the greatest potential for success.” 1554

来源：资阳报